Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones
Year: 2011
Type: article
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4232071580
